Skip to content
No picture yet

PMS-Clonazepam-R 0.5 mg – DIN 02207818

PMS-Clonazepam-R is Clonazepam 0.5 mg (tablet), sold in Canada. It is used for panic disorder, bipolar disorder and schizophrenia. It is supplied by Pharmascience Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Clonazepam 0.5 mg

Brand
PMS-Clonazepam-R
Strength
0.5 mg
Used for
Panic disorder, bipolar disorder and schizophrenia
Form
Tablet
Manufacturer
Pharmascience Inc
Drug class
Benzodiazepine (anxiety, sleep and seizure medicine)
Sold in
Canada
DIN
02207818

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Clonazepam pills and guides

What is Clonazepam used for?

Clonazepam is used for panic disorder, bipolar disorder, schizophrenia and seizures.

Medicine type
Benzodiazepine (anxiety, sleep and seizure medicine)
Official uses from the US prescribing label

Seizure Disorders: Clonazepam tablets are useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. In patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam tablets may be useful.

Some loss of effect may occur during the course of clonazepam treatment (see PRECAUTIONS: Loss of Effect ).

Panic Disorder: Clonazepam tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks.

The efficacy of clonazepam tablets was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the DSM-IIIR category of panic disorder (see CLINICAL PHARMACOLOGY: Clinical Trials ).

Panic disorder (DSM-V) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: palpitations, pounding heart or accelerated heart rate; sweating; trembling or shaking; sensations of shortness of breath or smothering; feeling of choking; chest pain or discomfort; nausea or abdominal distress; feeling dizzy, unsteady, lightheaded or faint; derealization (feelings of unreality) or depersonalization (being detached from oneself); fear of losing control; fear of dying; paresthesias (numbness or tingling sensations); chills or hot flushes.

The effectiveness of clonazepam tablets in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use clonazepam tablets for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION ).

From the FDA-approved label on DailyMed (published Sep 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02207818.
  • It names PMS-Clonazepam-R, Clonazepam 0.5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as PMS-Clonazepam-R by Pharmascience Inc.

In Canada: TARGETED SUBSTANCES (CDSA IV).

Ingredients

Active: Clonazepam

Other Clonazepam pills